Composition of neurofibromas, NF1 expression, and comparison of normal and NF1 haploinsufficient cells

Monographs in Human Genetics

Volumn 16, Issue , 2008, Pages 129-142

  Peltonen, J ^a   Peltonen, S ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870209838     PISSN: 00770876     EISSN: 16623835     Source Type: Book Series    
DOI: 10.1159/000126565     Document Type: Article

References (61)

1. Evans GR, Scheithauer B, Komminoth P, Peltonen J: Neurofibromatosis 1; in: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds): WHO Classification of Tumours. Pathology & Genetics: Tumours of Endocrine Organs, Chapter 5: Inherited Tumour Syndromes. Lyon IARC Press, 2004, pp 243-248.
2. Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, et al: Cellular differentiation and expression of matrix genes in type 1 neurof ibromatosis. Lab Invest 1988;59:760-771. (Pubitemid 19019457)
3. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF: Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 2002;296:920-922. (Pubitemid 34464899)
4. Maertens O, Brems H, Van De Sompele J, De Raedt T, Heyns I, et al: Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mutat 2006;10:1030-1040. (Pubitemid 44454056)
5. Hirose T, Sano T, Hizawa K: Ultrastructural localization of S-100 protein in neurofibroma. Acta Neuropathol (Berl) 1986;69:103-110. (Pubitemid 16146257)
6. Lassmann H, Jurecka W, Gebhart W: Some electron microscopic and autoradiographic results concerning cutaneous neurofibromas in von Recklinghausen's disease. Arch Dermatol Res 1976;255:69-81.
7. Ross AH, Herlyn M, Maul GG, Koprowski H, Bothwell M, et al: The nerve growth factor receptor in normal and transformed neural crest cells. Ann N Y Acad Sci 1986;486:115-123. (Pubitemid 17027493)
8. Carroll SL, Stonecypher MS: Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling. J Neuropathol Exp Neurol 2005;64:1-9. (Pubitemid 40189473)
9. Erlandson RA, Woodruff JM: Peripheral nerve sheath tumors: an electron microscopic study of 43 cases. Cancer 1982;49:273-287. (Pubitemid 12211842)
10. Perentes E, Nakagawa Y, Ross GW, Stanton C, Rubinstein LJ: Expression of epithelial membrane antigen in perineurial cells and their derivatives. An immunohistochemical study with multiple markers. Acta Neuropathol (Berl) 1987;75:160-165. (Pubitemid 18011899)
11. Hirose T, Tani T, Shimada T, Ishizawa K, Shimada S, Sano T: Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors. Mod Pathol 2003;16:293-298. (Pubitemid 36443977)
12. Pummi K, Yla-Outinen H, Peltonen J: Oscillation and rapid changes of NF1 mRNA steady-state levels in cultured human keratinocytes. Arch Dermatol Res 2000;8:422-424. (Pubitemid 30618110)
13. Erlandson RA: Peripheral nerve sheath tumors. Ultrastruct Pathol 1985;9:113-122. (Pubitemid 16189770)
14. +/- mast cells. J Clin Invest 2003;112:1851-1861. (Pubitemid 38063708)
15. Peltonen J, Penttinen R, Larjava H, Aho HJ: Collagens in neurofibromas and neurofibroma cell cultures. Ann N Y Acad Sci 1986;486:260-270. (Pubitemid 17027505)
16. Jaakkola S, Peltonen J, Riccardi V, Chu ML, Uitto J: Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells, perineurial cells, and fibroblasts in mixed cultures. J Clin Invest 1989;84:253-261. (Pubitemid 19170117)
17. Lee TK, Friedman JM: Analysis of NF1 transcriptional regulatory elements. Am J Med Genet A 2005;137:130-135. (Pubitemid 41262678)
18. Wrabetz L, Feltri ML, Kim H, Daston M, Kamholz J, et al: Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells. Glia 1995;15:22-32.
19. Ylä-Outinen H, Aaltonen V, Björkstrand A-S, Hirvonen O, Lakkakorpi J, et al: Upregulation of tumor suppressor protein neurofibromin in normal wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-β1 (TGF-β1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts. J Invest Dermatol 1998;110:232-237. (Pubitemid 28144597)
20. Atit RP, Crowe MJ, Greenhalgh DG, Wenstrup RJ, Ratner N: The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 1999;112:835-842. (Pubitemid 29277981)
21. Kuorilehto T, Ekholm E, Nissinen M, Hietaniemi K, Hiltunen A, et al: NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis. J Histochem Cytochem 2006;54:363-370. (Pubitemid 43291281)
22. Hirvonen O, Lakkakorpi J, Aaltonen V, Hirvonen H, Rossi M, et al: Developmental regulation of NF1 tumor suppressor gene in human peripheral ner ve. J Neurocytol 1998;27:939-952. (Pubitemid 29522757)
23. Kuorilehto T, Nissinen M, Koivunen J, Benson MD, Peltonen J: NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res 2004;19:983-989. (Pubitemid 41103455)
24. Griesser J, Kaufmann D, Maier B, Mailhammer R, Kuehl P, Krone W: Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors. J Invest Dermatol 1997;108:275-280. (Pubitemid 27116223)
25. Cichowski K, Santiago S, Jardim M, Johnson BW, Jacks T: Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev 2003;17:449-454. (Pubitemid 36258759)
26. Nishi T, Lee PS, Oka K, Levin VA, Tanase S, et al: Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene 1991;6:1555-1559. (Pubitemid 21924257)
27. Gutmann DH, Geist RT, Rose K, Wright DE: Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues. Dev Dyn 1995;202:302-311.
28. Kaufmann D, Muller R, Kenner O, Leistner W, Hein C, et al: The N-terminal splice product NF1-10a-2 of the NF1 gene codes for a transmembrane segment. Biochem Biophys Res Commun 2002;294:496-503. (Pubitemid 34694121)
29. Van Den Broucke I, Van De Sompele J, De Paepe A, Messiaen L: Quantification of NF1 transcripts reveals novel highly expressed splice variants. FEBS Lett 2002;522:71-76. (Pubitemid 34722500)
30. Baralle M, Skoko N, Knezevich A, De Conti L, Motti D, et al: NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region. FEBS Lett 2006;580:4449-4456. (Pubitemid 44118266)
31. Haeussler J, Haeusler J, Striebel AM, Assum G, Vogel W, et al: Tumor antigen HuR binds specifically to one of five protein-binding segments in the 3'-untranslated region of the neurofibromin messenger RNA. Biochem Biophys Res Commun 2000;267:726-732. (Pubitemid 30099391)
32. 2+-induced keratinocyte differentiation. Lab Invest 2002;82:353-361. (Pubitemid 34242528)
33. Kaufmann D, Bartelt B, Hoffmeyer S, Muller R: Posttranslational regulation of neurofibromin content in melanocytes of neurofibromatosis type 1. Arch Dermatol Res 1999;291:312-317. (Pubitemid 29281319)
34. Korkiamaki T, Yla-Outinen H, Leinonen P, Koivunen J, Peltonen J: The effect of extracellular calcium concentration on calcium-mediated cell signaling in NF1 tumor suppressor-deficient keratinocytes. Arch Dermatol Res 2005;296:465-472. (Pubitemid 40487358)
35. Mangoura D, Sun Y, Li C, Singh D, Gutmann DH, et al: Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene 2006;25:735-745. (Pubitemid 43214700)
36. Hermonen J, Hirvonen O, Yla-Outinen H, Lakkakorpi J, Bjorkstrand AS, et al: Neurofibromin: expression by normal human keratinocytes in vivo and in vitro and in epidermal malignancies. Lab Invest 1995;73:221-228.
37. Izawa I, Tamaki N, Saya H: Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. FEBS Lett 1996;382:53-59. (Pubitemid 26092233)
38. De Schepper S, Boucneau JM, Westbroek W, Mommaas M, Onderwater J, et al: Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes. J Invest Dermatol 2006;126:653-659. (Pubitemid 43255656)
39. Xu GF, Lin B, Tanaka K, Dunn D, Wood D, et al: The catalytic domain of neurofibromatosis type I gene product stimulates ras GTPase and complements ira mutants of S. cerevisae. Cell 1990;63:835-841. (Pubitemid 120035056)
40. Hsueh YP, Roberts AM, Volta M, Sheng M, Roberts RG: Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans. J Neurosci 2001;21:3764-3770. (Pubitemid 32466468)
41. Bollag G, McCormick F, Clark R: Characterization of full-length neurofibromin: tubulin inhibits Ras-GAP activity. EMBO J 1993;12:1923-1927. (Pubitemid 23157708)
42. Gregory PE, Gutmann DH, Mitchell A, Park S, Boguski M, et al: Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet 1993;19:265-274. (Pubitemid 23216308)
43. Koivunen J, Yla-Outinen H, Korkiamaki T, Karvonen SL, Poyhonen M, et al: New function for NF1 tumor suppressor. J Invest Dermatol 2000;114:473-479. (Pubitemid 30415332)
44. Li C, Cheng Y, Gutmann DA, Mangoura D: Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. Brain Res Dev Brain Res 2001;130:231-248. (Pubitemid 33000087)
45. Van Den Broucke I, Van Oostveldt P, Coene E, De Paepe A, Messiaen L: Neurofibromin is actively transported to the nucleus. FEBS Lett 2004;560:98-102. (Pubitemid 38264300)
46. Daston MM, Ratner N: Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev Dyn 1992;195:216-226. (Pubitemid 23119299)
47. Huynh DP, Nechiporuk T, Pulst SM: Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev Biol 1994;161:538-551. (Pubitemid 24077422)
48. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, et al: Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crestderived tissues. Genes Dev 1994;8:1019-1029. (Pubitemid 24145666)
49. Malminen M, Peltonen S, Koivunen J, Peltonen J: Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis. BMC Dermatol 2002;2:10.
50. Korkiamäki T, Ylä-Outinen H, Koivunen J, Karvonen S-L, Peltonen J: Altered calcium mediated cell signaling in keratinocytes cultured from patients with neurofibromatosis type 1. Am J Pathol 2002;160:1981-1990. (Pubitemid 34663391)
51. Wu M, Wallace MR, Muir D: Nf1 haploinsufficiency augments angiogenesis. Oncogene 2006;25:2297-2303.
52. Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A: Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 1999;18:4450-4459. (Pubitemid 29396653)
53. +/- mast cells. J Immunol 2007;178:2527-2534. (Pubitemid 46233454)
54. +/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. Hum Mol Genet 2006;15:2421-2437. (Pubitemid 44288696)
55. Lyden D, Hattori K, Dias S: Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursor cells block tumor angiogenesis and growth. Nat Med 2001;7:1194-1201. (Pubitemid 33063774)
56. Teixeira F, Martinez-Palomo A, Riccardi VM, Fernandez-Diez J: Vascular changes in cutaneous neurofibromas. Neurofibromatosis 1988;1:5-16.
57. Ozerdem U: Targeting neovascular pericytes in neurofibromatosis type 1. Angiogenesis 2004;7:307-311. (Pubitemid 40767932)
58. Munchhof AM, Li F, White HA, Mead LE, Krier TR, et al: Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurof ibromin-deficient endothelial cells. Hum Mol Genet 2006;15:1858-1869. (Pubitemid 43821776)
59. Sheela S, Riccardi VM, Ratner N: Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol 1990;111:645-653.
60. Mashour GA, Ratner N, Khan GA, Wang HL, Martuza RL, Kurtz A: The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibromaderived cells. Oncogene 2001;20:97-105. (Pubitemid 32142342)
61. Riccardi VM: The genetic predisposition to and histogenesis of neurofibromas and neurofibrosarcoma in neurofibromatosis type 1. Neurosurg Focus 2007;22:E31-11.